glp-1 drugs and alzheimer's Details of failed studies cast pall on Novo Nordisk's as treatment GLP-1 Drugs May Help Prevent
Description
doi: 10.1016/j.molmet.2019.09.010 42 AndrikouETsioufisCAndrikouILeontsinisITousoulisDPapanasN
Many patients scale up gradually as their body adapts, spreading costs across several months
As such, even limited exposure to hazardous substances could harm infants
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management
Beyond CagriSema, researchers are exploring GLP-1 combined with FGF21 analogues, GLP-1 combined with leptin sensitizers, and even triple or quadruple receptor agonists
